Virtual Medicinal Product (VMP) - Atezolizumab 1.875g/15ml solution for injection vials
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Atezolizumab 1.875g/15ml solution for injection vials | Start Date 20-09-2023 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 15.0
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.subcutaneous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L01FF05
- BNF Codes
-
- BNF code 08010500
| Code | Start Date | End Date |
|---|---|---|
| 42264711000001102 | 20-09-2023 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Atezolizumab | Based on Ingredient Substance | 125 mg | 1 ml |
Name
Atezolizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
125.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMAtezolizumab
-
VMP(Current) Atezolizumab 1.875g/15ml solution fo...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 vial |